5ЈTOP is invariably a cytosine, which is succeeded by A'Beckett Street, Melbourne,Victoria 3000, Australia a stretch of 5-14 pyrimidines, varying in length and 3 Corresponding author composition, depending on the particular transcript. In growth-arrested cells, these mRNA transcripts are distribTreatment of mammalian cells with the immunouted between mRNP particles and small polysomes, made suppressant rapamycin, a bacterial macrolide, selectup largely of monosomes and disomes. Unlike most ively suppresses mitogen-induced translation of an cellular mRNAs which redistribute to polysomes of the essential class of mRNAs which contain an oligopyrimisame size following mitogenic stimulation, 5ЈTOP mRNAs dine tract at their transcriptional start (5ЈTOP), most redistribute to polysomes of larger size, the mean distribunotably mRNAs encoding ribosomal proteins and tion being dependent on the length of the transcript elongation factors. In parallel, rapamycin blocks . This selective regulation of 5ЈTOP mitogen-induced p70 ribosomal protein S6 kinase mRNAs appears to be dependent on the polypyrimidine (p70 s6k ) phosphorylation and activation. Utilizing tract as well as its location at the transcriptional start site chimeric mRNA constructs containing either a wild- (Meyuhas et al., 1996) . This conclusion is based on several type or disrupted 5ЈTOP, we demonstrate that an intact observations; (i) fusing the 5Ј-untranslated region (5ЈUTR) polypyrimidine tract is required for rapamycin to of a 5ЈTOP mRNA to a non-5ЈTOP mRNA confers elicit an inhibitory effect on the translation of these translational control on the chimeric transcript (Mariottini transcripts. In turn, a dominant-interfering p70 s6k , and Amaldi, 1990; Hammond et al., 1991; Levy et al. , which selectively prevents p70 s6k activation by blocking 1991), (ii) whereas placing the 5ЈTOP motif within the phosphorylation of the rapamycin-sensitive sites, sup-5ЈUTR of a non-5ЈTOP mRNA does not confer translapresses the translation of the chimeric mRNA contional control on the chimeric transcript (Levy et al., 1991 ; taining the wild-type but not the disrupted 5ЈTOP. Avni et al., 1994) , and (iii) substitution of a single purine Conversion of the principal rapamycin-sensitive p70 s6k in the ϩ1 position for the cytosine abolishes translational phosphorylation site, T389, to an acidic residue confers control of the chimeric transcript (Levy et al., 1991) . rapamycin resistance on the kinase and negates the Although little is known concerning the mechanism by inhibitory effects of the macrolide on 5ЈTOP mRNA which the acute translational up-regulation of 5ЈTOP translation in cells expressing this mutant. The results mRNAs is controlled, recent studies have demonstrated demonstrate that the rapamycin block of mitogenthat their expression is suppressed selectively by the induced 5ЈTOP mRNA translation is mediated through immunosuppressant rapamycin, suggesting that the FRAP/ inhibition of p70 s6k activation.
Introduction
FRAP or mTOR (Brown et al., 1994; Sabatini et al., 1994; Sabers et al., 1995) . Though mTOR/FRAP has The biogenesis of translational components plays an homology to both lipid and protein kinases, the only allied essential role in the growth and proliferation of cells in activity identified to date is autophosphorylation (Brown response to a mitogenic signal (Nasmyth, 1996) . In the et al., Brunn et al., 1996) . Rapamycin treatment of case of ribosomes, many of the protein and RNA constitucells also leads to the dephosphorylation and inactivation ents are structurally well characterized (Wool et al., 1996) ; of the p70 s6k and, in parallel, the dephosphorylation of however, little is known concerning the mechanisms ribosomal protein S6 (Chung et al., 1992; , and signalling pathways responsible for regulating their 1994a). Furthermore, a point mutant of mTOR/FRAP, coordinate expression. Recent studies have shown that the which fails to bind the rapamycin-FKBP12 inhibitory mRNA transcripts for all ribosomal proteins studied to complex, when transiently co-transfected with p70 s6k prodate, as well as protein synthesis elongation factors, tects the kinase from inactivation by the macrolide (Brown contain an unusual oligopyrimidine tract at their transcripet al., 1995) . The latter studies lent support to the tional start site, termed a 5ЈTOP, which confers translational control on their expression in response to mitogens hypothesis that mTOR/FRAP is an upstream activator of the p70 s6k . Since p70 s6k has been implicated in translation either suppress mitogen-induced 5ЈTOP mRNA translation or to protect it from the inhibitory effects of rapamycin. through S6 phosphorylation (Jefferies and Thomas, 1996) , the effect of rapamycin on protein synthesis was examined. Rapamycin pre-treatment of mitogen-stimulated Swiss
Results
3T3 cells caused only an~10-15% inhibition of global protein synthesis; however, it severely repressed the Rapamycin requires intact 5ЈTOP to exert an inhibitory effect recruitment of 5ЈTOP mRNAs into polysomes with no effect observed on the translation of the non-5ЈTOP-To address the importance of the 5ЈTOP motif in serving as the inhibitory target of rapamycin in suppressing the containing mRNAs coding for β-actin, protein synthesis initiation factor eIF-4A and β-tubulin (Jefferies et al., translation of 5ЈTOP mRNAs, advantage was taken of two NIH 3T3 cell lines stably expressing one of two 1994a). These studies led to the speculation that the p70 s6k , through S6 phosphorylation, is involved in the selective chimeric mRNA constructs (Avni et al., 1994) . The wildtype chimeric mRNA contains the first 29 nucleotides up-regulation of 5ЈTOP mRNAs. However, this model has been questioned by the recent observation that, in response from the 5ЈUTR of ribosomal protein S16, including the 5ЈTOP, fused to the human growth hormone (hGH) mRNA, to mitogens, the phosphorylation of at least three other translational components also are affected by rapamycin.
whereas the mutant chimeric construct has five of the eight pyrimidines forming the 5ЈTOP replaced by purines None of these three proteins, including initiation factor eIF-4E (Mendez et al., 1996) , the eIF-4E repressor 4E-( Figure 1A and B). In quiescent cells, the majority of wild-type S16-hGH transcript sediments with mRNP BP1 (Beretta et al., 1996) and the kinase which modulates elongation factor eEF-2 phosphorylation, calcium calparticles or as monosomes/disomes, whereas the addition of serum induces both populations to relocalize to modulin-dependent kinase III (Redpath et al., 1996) , are substrates for the p70 s6k .
polysomes containing 7-9 ribosomes per transcript ( Figure  1C , left and middle panels, respectively). These results The finding that mTOR/FRAP, based on the inhibitory effects of rapamycin, has a number of potential downare very similar to those reported for elongation factor-1α (eEF-1α) and other 5ЈTOP mRNAs (Jefferies et al., stream translational targets has put into question the role of p70 s6k in regulating 5ЈTOP mRNA expression (Lin 1994a; Terada et al., 1994) . In contrast, disruption of the 5ЈTOP by insertion of the five purines abolishes et Proud, 1996) . To address this issue further would require more precise tools than rapamycin. Such translational regulation of the mutant cm5S16-hGH chimeric mRNA such that most of the transcript is tools might be generated by utilizing recently described p70 s6k phosphorylation site mutants. Activation of p70 s6k now found associated with polysomes containing~7-9 ribosomes per transcript, regardless of growth state (Figure is associated with two distinct sets of mitogen-induced phosphorylation sites. The first set of sites are flanked by 1C, compare left and middle panels). If serum-stimulated cells expressing the wild-type S16-hGH transcript were a proline in the ϩ1 position, exhibit rapamycin resistance, except for S411, and reside within an autoinhibitory treated with rapamycin, little effect was observed on global translation based on polysome profiles ( Figure 1C , domain whose function appears to modulate kinase activity (Han et al., 1995; Mahalingam and Templeton, 1996) . In compare middle and right panels); however, the wild-type chimeric transcript largely redistributes from polysomes contrast, the second set of sites are rapamycin sensitive and are flanked by large aromatic residues (Pearson et al., to mRNP particles and monosomes/disomes (Figure1C, right panel). In striking contrast to the wild-type chimeric 1995). Two of these sites, T229 in the activation loop and T389 in the conserved linker region, appear essential for transcript, rapamycin treatment of stimulated cells expressing the mutant cm5S16-hGH mRNA had no measkinase activity based on the finding that substitution of an alanine at either site ablates kinase activity (Pearson urable effect on message distribution, with the mRNA remaining associated with polysomes. In parallel, stimulaet al., 1995) . Kinase-dead mutants, harbouring a neutral residue in the phosphorylation site of the activation loop, tion of either cell type leads to an increase in p70 s6k activity as compared with quiescent cells ( Figure 1D , in some instances have been shown to act as dominantinterfering mutants preventing signalling to downstream compare lanes 2 and 5 with 1 and 4, respectively), with the addition of rapamycin totally abolishing this response targets (Pagès et al., 1993) . Furthermore, T389, the principal target of rapamycin-induced p70 s6k dephosphoryla-( Figure 1D , lanes 3 and 6). Although rapamycin abolishes p70 s6k activity, it only suppresses 5ЈTOP mRNA translation and inactivation, when converted to an acidic residue, confers rapamycin resistance on the kinase (Pearson et al., tion, suggesting that, if the effects of rapamycin are exerted through p70 s6k , there must be a rapamycin/p70 s6k -1995) . When used in combination, these phosphorylation site mutants could be exploited to designate downstream independent pathway involved in this response. Collectively, the results also demonstrate that an intact oligofunctional targets.
To evaluate the model that rapamycin inhibits 5ЈTOP pyrimidine tract is required for rapamycin to exert its effect on the translation of 5ЈTOP mRNAs. translation through blocking the ability of p70 s6k to signal to the polypyrimidine tract, it was first determined whether an intact polypyrimidine tract was required for the Effect of a dominant-interfering mutant on p70 s6k activation macrolide to exert its inhibitory effect on translational upregulation of these mRNAs. Next, a potential dominant-A powerful tool in identifying upstream mediators of specific signalling pathways has been the use of dominantinterfering mutant of p70 s6k was examined for its effect on reporter p70 s6k activity as well as for its selectivity for interfering mutants. In the case of kinases, dominantinterfering mutants have been generated by mutating either this kinase. Finally, the dominant-interfering and rapamycin-resistant mutants were examined for their ability to the essential lysine in the conserved ATP-binding pocket p70 s6k regulates 5ЈTOP mRNA translation
Fig. 1.
Rapamycin suppresses translation by a mechanism requiring a 5ЈTOP. Two NIH 3T3 cell lines were used. (A) One cell line was stably transfected with a wtS16-hGH chimeric gene under the control of the S16 promoter which generated a chimeric mRNA where 29 nucleotides of the 5ЈUTR of S16 were joined to the hGH coding region. (B) The second cell line was stably transfected with a cm5S16-hGH mutant gene which generated an identical transcript except that five of the pyrimidines were mutated to purines. (C) Cytoplasmic extracts were prepared from the two NIH 3T3 cell lines either quiesced (left panel), stimulated with 10% FCS for 3 h (middle panel) or stimulated with FCS for 3 h and then treated for an additional 1 h with 20 nM rapamycin (right panel). wtS16-hGH chimeric mRNA is indicated by (j) and cm5S16-hGH chimeric mRNA by (s). The extracts were centrifuged on 17.1-40% linear sucrose gradients, fractionated and subjected to Northern blot analysis using a probe directed against the hGH portion of the chimeric transcripts. Blots were then developed with a PhosphorImager (Molecular Dynamics) and the signal from each gradient fraction was quantified using Imagequant software (Molecular Dynamics) and calculated as a percentage of the total signal from the 14 fractions. The shaded areas depict the OD 260 nm polysome gradient profile from the NIH 3T3 cells under the indicated conditions, and the position of the 80S peak is noted. (D) Immunocomplex assays of p70 s6k from the two NIH 3T3 cell lines expressing either wtS16-hGH chimera (lanes 1-3) or cm5S16-hGH chimera (4-6). Kinase activity was assayed from quiescent cells (lanes 1 and 4), cells stimulated with 10% FCS for 3 h (lanes 2 and 5) or cells stimulated with FCS for 3 h and then treated for an additional 1 h with 20 nM rapamycin (lanes 3 and 6). S6 in 40S ribosomal subunits was used as substrate. (Sanchez et al., 1994) or a critical phosphorylation site in transient overexpression of a kinase-inactive mutant, p70 s6k A229, might function as a dominant-interfering the activation loop, such that kinase activity of the resulting construct is ablated (Pagès et al., 1993) . When transiently mutant. To test this possibility, a myc-and glutathione S-transferase (GST)-tagged p70 s6k reporter construct, overexpressed, these mutants are thought to act by sequestering upstream activators, preventing the activation of myc-p70 s6k -GST, was co-transfected with increasing amounts of the myc epitope-tagged-p70 s6k A229 construct the endogenous enzyme. Recently, T229 in the activation loop of p70 s6k was identified as a principal phosphorylation in human 293 cells. These cells were chosen because of their high transfection efficiency, and the fact that they site associated with kinase activation Weng et al., 1995a) . Since substitution of T229 by either regulate 5ЈTOP expression in a similar manner to that observed for 3T3 cells (see below). The results demonstrate an acidic or neutral residue ablated kinase activity Weng et al., 1995a) , it was reasoned that that increasing amounts of transfected myc-p70 s6k A229 Fig. 2 . Expression of dominant-interfering p70 s6k A229 blocks p70 s6k , but not p44 mapk activation. (A and B) 293 cells were transiently transfected using a calcium phosphate method with 1 μg of myc-p70 s6k -GST plasmid alone (lane 1) or co-transfected with increasing amounts of mycp70 s6k A229 plasmid (lanes 2-6, 0.5, 1, 2, 5 and 10 μg of plasmid DNA respectively). Following 24 h serum starvation and 45 min of FCS (10%) treatment, cell extracts were prepared and equal amounts of total protein were resolved by SDS-PAGE and subjected to Western blot analysis. The membrane was probed with 9E10 antibody to analyse the expression level of the two myc epitope-tagged forms of p70 s6k and detected by fluorometry (A). (B) Reporter myc-p70 s6k -GST, was purified from cell extracts using glutathione-Sepharose and assayed for S6 kinase activity using 40S ribosomal subunits. (C and D) 293 cells were transiently transfected with 1 μg of HA-p44 mapk plasmid alone (lane 1) or co-transfected with 0.5 (lane 2) or 10 μg (lane 3) of myc-p70 s6k A229 plasmid. Cells were serum starved for 24 h and then stimulated for 10 min with FCS (10%). Extracts were analysed for HA-p44 mapk and myc-p70 s6k A229 protein expression on Western blots probed with a mix of 9E10 (myc epitope tag) and 12CA5 (HA tag) antibodies which were then detected by fluorometry (C) as described in Materials and methods. (D) HA-p44 mapk was immunoprecipitated with 12CA5 antibody and assayed for MBP kinase activity.
blocked reporter myc-p70 s6k -GST activation in a doseunaffected. Interestingly, the phosphorylation sites affected are identical to those blocked by rapamycin pre-treatment dependent manner, as measured in an activity assay employing S6 as a substrate (Figure 2A and B). It should (Han et al., 1995; . It should be noted that the phosphopeptides migrating above the origin have be noted that a similar dominant-interfering mutant has been obtained by altering the lysine in the ATP-binding pocket been determined to be distinct from T229-and T389-containing phosphopeptides by converting both sites to serine to glutamine (P.B.Dennis and G.Thomas, unpublished data). That the dominant-interfering effect of myc-p70 s6k A229
and analysing individual peptides for phosphoamino acid content (data not shown). Thus, not only is the dominantwas specific for the p70 s6k was shown by the fact that its overexpression had no effect on the serum-induced activainterfering construct specific for p70 s6k , but it selectively blocks the phosphorylation of the same subset of sites as tion of co-transfected haemagglutinin (HA)-tagged p44 mapk in an immune complex assay employing myelin basic prorapamycin, most likely by competing for a proximal upstream activator of p70 s6k . tein (MBP) as a substrate ( Figure 2C and D) . The results also demonstrate that increased expression of the dominantnegative construct has no effect on the expression of either Effect of a dominant-interfering mutant on 5ЈTOP mRNA translation reporter construct, myc-p70 s6k -GST or HA-p44 mapk (Figure 2A and C, respectively) . Thus the p70 s6k A229 construct acts As the dominant-interfering myc-p70 s6k A229 construct specifically blocks p70 s6k activation, we reasoned that it as a selective inhibitor of the p70 s6k signal transduction pathway. Surprisingly, the amount of 32 P incorporated into would serve to discern whether the inhibitory effects of rapamycin on 5ЈTOP translation are through inhibition of myc-p70 s6k -GST in the absence and presence of mycp70 s6k A229 was indistinguishable (data not shown), sugthe kinase. To test this possibility, 293 cells were cotransfected with cDNA constructs expressing either the gesting either that the inhibitory effect was not through an upstream kinase or that the phosphorylation of only a wild-type or mutant S16-hGH chimeric mRNAs in combination with either the empty vector or the vector minor subset of sites was being affected by the dominantinterfering construct. To address this point, twoexpressing the myc-p70 s6k A229 construct. The mutant cm5S16-hGH chimeric mRNA in the presence of empty dimensional phosphopeptide maps were analysed of the reporter myc-p70 s6k -GST derived from either serum-stimuvector was translated efficiently and associated with polysomes in both quiescent and serum-stimulated cells lated cells co-expressing the empty vector or the dominantinterfering mutant myc-p70 s6k A229. As compared with ( Figure 4A ), consistent with the results obtained in NIH 3T3 cells ( Figure 1C left and middle panels). Furthermore, expression of the reporter alone, co-expression in the presence of the dominant-interfering mutant blocked phosphoco-expression of dominant-negative myc-p70 s6k A229 did not affect the distribution of the mutant cm5S16-hGH rylation of T229, in the activation loop, as well as T389 and S404, in the linker region (see Figure 3A) , and significantly chimeric mRNA in either quiescent or serum-stimulated cells (compare Figure 4A and B) . In serum-deprived reduced phosphorylation of S411 in the autoinhibitory domain ( Figure 3B and C, respectively). The phosphoryla-293 cells, the transiently expressed wild-type S16-hGH chimeric mRNA co-expressed with the vector alone tion of T229 and T389 appears critical for kinase activation Dennis et al., 1996) . In contrast, behaved in a similar manner to that observed under stable expression conditions in NIH 3T3 cells, except that more the remaining major phosphorylation sites, including S418, T421 and S424 in the autoinhibitory domain, are largely of the wild-type mRNA partitioned with the monosome/ p70 s6k regulates 5ЈTOP mRNA translation figure. (B) 293 cells were transfected with 1 μg of reporter myc-p70 s6k -GST alone or (C) together with 5 μg of myc-p70 s6k A229, serum starved for 24 h in phosphate-free DMEM and labelled with 32 P for 7 h. After 45 min stimulation with phosphate-free FCS (10%), the myc-p70 s6k -GST was precipitated and analysed on two-dimensional tryptic/chymotrypsin phosphopeptide maps employing PhosphoImager and ImageQuant software (Molecular Dynamics) as described in Materials and methods. The origin is marked with an arrow.
disome fraction than observed in NIH 3T3 cells (compare implicated in the translational up-regulation of 5ЈTOP mRNAs. Thus the dominant-interfering p70 s6k A229 Figure 4C with Figure 1C , left panel). This difference may reflect the fact that it is more difficult to quiesce 293 mimics the inhibitory effects of rapamycin on the translation of 5ЈTOP mRNAs. cells, possibly as a consequence of being transformed with the E1A oncogene of adenovirus (Graham et al., 1977) . Following serum stimulation, most of the wildRapamycin-resistant T389E mutant A caveat with the dominant-interfering approach is that type chimeric mRNA relocated from the monosome/ disome fraction to polysomes of 7-8 ribosomes per parallel pathways which bifurcate directly upstream of p70 s6k may also be inhibited. To address this issue, we transcript ( Figure 4C ). Similar results were obtained if the wild-type p70 s6k was co-transfected with the wild-type asked whether a rapamycin-resistant mutant of p70 s6k , where the principal site of rapamycin-induced p70 s6k S16-hGH chimeric mRNA (data not shown). However, the serum-induced relocation of the wild-type chimeric dephosphorylation, T389, has been changed to a glutamic acid Dennis et al., 1996) , was mRNA was repressed in the presence of the dominantinterfering myc-p70 s6k A229 construct (compare Figure  sufficient to maintain serum-stimulated 5ЈTOP mRNA translation in the presence of the macrolide. As the 4D with C), resembling the effect observed in serumstimulated NIH 3T3 cells treated with rapamycin ( Figure  transfection efficiency of 293 cells is high, the p70 s6k E389 construct should generate a signal above background, 1C, right panel). However, as noted for rapamycin, the dominant-interfering myc-p70 s6k A229 construct, despite precluding the use of the wild-type reporter mRNA construct. Thus, the distribution of endogenous eEF-1α abolishing p70 s6k activity, only partially suppresses the translational up-regulation of the S16-hGH chimeric mRNA, which we have shown previously to be suppressed by rapamycin (Jefferies et al., 1994a) , was followed on mRNA. These findings support the hypothesis that seruminduced p70 s6k independent signalling pathways are also polysome profiles from 293 cells transiently expressing Fig. 4 . Dominant-interfering effect of myc-p70 s6k A229 on the polysome distribution of chimeric mRNAs. 293 cells were transiently transfected with (A) 2 μg of cm5S16-hGH construct co-transfected with 10 μg of empty CMV-plasmid, (B) 2 μg of cm5S16-hGH construct co-transfected with 10 μg of myc-p70 s6k A229 plasmid, (C) 2 μg of wtS16-hGH construct co-transfected with 10 μg of empty CMV-plasmid and (D) 2 μg of wtS16-hGH construct co-transfected with 10 μg of myc-p70 s6k A229 plasmid. Cytoplasmic extracts were made from cells serum starved for 26 h (u) or serum starved and then stimulated with 10% FCS for 4 h (d). Extracts were analysed as described in Figure1 on 17.1-40% linear sucrose gradients. In each case, the shaded areas depict the OD 260 nm polysome gradient profile from the serum-stimulated 293 cell extract under the indicated conditions with the position of the 80S peak noted.
either the wild-type p70 s6k or the rapamycin-resistant translational up-regulation of the eEF-1α transcript ( Figure  5B ). In contrast, the rapamycin-resistant p70 s6k E389 conp70 s6k E389. In quiescent cells, eEF-1α mRNA partitioned with monosome/disomes and mRNP particles in the struct almost completely protected eEF-1α from the inhibitory effects of rapamycin ( Figure 5D ). Indeed, if the presence of either wild-type myc-p70 s6k or the rapamycinresistant mutant myc-p70 s6k E389 kinase construct (Figure efficiency of transfection is considered, which was between 70 and 80%, the protection would appear complete, in 5A and C, respectively). As for the transiently expressed wild-type S16-hGH chimeric transcript ( Figure 4C ), more agreement with results obtained with the wild-type S16-hGH chimeric transcript (data not shown). Consistent with eEF-1α mRNA partitioned proportionally with monosome/ disomes than observed earlier in 3T3 cells (Jefferies et al., these findings, cells expressing p70 s6k E389, as compared with the wild-type construct, display high kinase activity 1994a). Following serum stimulation, eEF-1α transcripts largely redistributed to polysomes of 11-12 ribosomes following rapamycin treatment ( Figure 5E ). Although the p70 s6k E389 construct has high basal activity, its overper transcript, with slightly higher levels recruited to polysomes in the case of cells expressing the mycexpression in the absence of mitogen stimulation does not induce the translational up-regulation of eEF-1α p70 s6k E389 construct (compare Figure 5B with D) . We consistently have observed slightly higher levels of recruittranscripts, indicating that p70 s6k activation is not sufficent to induce this response. Nevertheless, a rapamycinment when employing either the p70 s6k E389 or the more active p70 s6k D3E-E389 variant. More importantly, as in resistant p70 s6k is sufficient in protecting 5ЈTOP mRNAs from the inhibitory effects of the macrolide and supports the case of the stably expressed wild-type S16-hGH chimeric transcript, rapamycin treatment suppressed the the hypothesis that the dominant-negative p70 s6k A229 p70 s6k regulates 5ЈTOP mRNA translation . Cytoplasmic extracts were prepared from cells treated as described above and centrifuged on 17.1-51% linear sucrose gradients, fractionated and subjected to Northern blot analysis using a probe directed against eEF-1α mRNA (Jefferies et al., 1994a) . Blots were then analysed as in Figure 1 . The shaded areas depict the OD 260 nm polysome gradient profile from 293 cells under the indicated conditions. (E) 293 cells were transiently transfected with either myc-p70 s6k (lanes 1 and 3) or myc-p70 s6k E389 (lanes 2 and 4). Extracts were prepared after a 26 h serum deprivation (lanes 1 and 2) or after a 26 h serum deprivation followed by an additional 4 h in 10% serum in which 20 nM rapamycin was added for the last 1 h (lanes 3 and 4). S6 kinase activity was measured in an immunocomplex assay using 9E10 antibody. Data are shown as a percentage of the 10% FCS-stimulated activity at 3 h in each case.
blocks translation of 5ЈTOP mRNAs through inhibition family of mRNAs is exerted through inhibition of the kinase. Furthermore, it is clear that the inhibitory effects of endogenous p70 s6k .
of both rapamycin and the dominant-interfering p70 s6k mutant on 5ЈTOP mRNA translation require an intact Discussion polypyrimidine tract (Figures 1 and 4) . This last finding is consistent with the fact that the dominant-interfering The data presented here point to a central role for p70 s6k in the selective translational up-regulation of 5ЈTOP p70 s6k mutant preferentially blocks the equivalent phosphorylation sites in a reporter p70 s6k as does rapamymRNAs in response to mitogens and demonstrate that the inhibitory effects of rapamycin on the expression of this cin ( Figure 3 and . A tentative model depicting the signalling pathway leading to the activation mRNAs ( Figure 5 ), does not protect 4E-BP1 from dephosphorylation (S.von Manteuffel, P.B.Dennis and of the p70 s6k , and thus the translational up-regulation of 5ЈTOP mRNAs, has emerged recently (Brown and G.Thomas, unpublished data) , suggesting that 4E-BP1 may not be significantly implicated in the regulation of Schreiber, 1996) and is depicted in Figure 6 . In brief, mitogen stimulation is speculated to first trigger the these mRNAs. This observation is consistent with the finding that overexpression of eIF-4E, the inhibitory target activation of the phosphatidylinositol 3-OH kinase followed by activation of protein kinase B which would of 4E-BP1, does not result in the selective up-regulation of 5ЈTOP mRNAs (Avni et al., 1994) , and that the mutant function upstream of an as yet unidentified p70 s6k kinase (Downward, 1995) . In contrast, mTOR/FRAP exerts its cm5S16-hGH chimeric mRNA, containing the disrupted polypyrimidine tract, localizes to polysomes in the absence effects through a putative effector molecule which operates on the amino-terminus of p70 s6k , whose activity may or of mitogenic stimulation (Figures 1 and 3) . Moreover, given the role of unphosphorylated 4E-BP1 in inhibiting may not be regulated by mitogens (Weng et al., 1995b; Dennis et al., 1996) . However, a number of recent observageneral eIF-4E cap-dependent translation (Pause et al., 1994) , it is difficult to reconcile that rapamycin blocks tions are not wholly consistent with phosphatidylinositol 3-OH kinase and protein kinase B acting as upstream 4E-BP1 phosphorylation but has little effect on global protein synthesis in Swiss mouse 3T3 cells (Jefferies et al., components of the p70 s6k signal transduction pathway (for a discussion, see Dennis et al., 1996) . Similarly, the 1994a). It has been suggested that eIF-4E may be primarily important in the translation of a subset of mRNAs which existence of a rapamycin-sensitive effector molecule and the role of S6 in modulating the effects of p70 s6k on contain a highly structured 5ЈUTR, such as ornithine decarboxylase (Shantz and Pegg, 1994) , ornithine amino-5ЈTOP mRNAs have yet to be established (see below).
The mechanism by which the dominant-interfering transferase (Fagan et al., 1991) , cyclin D 1 (Rosenwald et al., 1995) , Q23 or p23 (Bommer et al., 1994) and myc p70 s6k A229 mutant blocks the same set of phosphorylation sites as rapamycin in the p70 s6k reporter is unknown; (DeBenedetti et al., 1994) . Nevertheless, we have noted that the translation of ornithine decarboxylase mRNA, however, it is most likely through competing for a proximal upstream activator which is rapamycin sensitive. Indeed, which can be augmented by the overexpression of eIF-4E (Shantz and Pegg, 1994) , is unaffected by treating either recent studies have demonstrated that co-expression of either the wild-type kinase or a kinase-dead construct, in Swiss 3T3 or 293 cells with rapamycin (data not shown). It may be that these differences can be attributed to cell which the conserved lysine in the ATP-binding site has been mutated, also block the same set of sites as observed type specificity or that additional factors are involved which have yet to be described. Indeed, there are a number with the dominant-interfering p70 s6k A229 mutant (P.B. Dennis and G.Thomas, unpublished data) . In all of eIF-4E-binding protein homologues (Pause et al., 1994) , thus 4E-BP1Јs role in regulating translation may be cases, an immediate upstream component is apparently sequestered, thus it is possible that parallel pathways that more subtle.
The requirement for p70 s6k activity for full translational bifurcate upstream of p70 s6k also may be affected. In support of this model, recent studies have shown that up-regulation of 5ЈTOP mRNAs implicates a downstream target of the protein synthetic apparatus as being responsinsulin-induced 4E-BP1 phosphorylation is blocked by p70 s6k A229 (S.von Manteuffel, P.B.Dennis and G.Thomas, ible for mediating this response. Despite intensive efforts, the only relevant in vivo physiological substrate found to unpublished data), confirming earlier results that p70 s6k and 4E-BP1 lie on a common signalling pathway. However, date for p70 s6k is 40S ribosomal protein S6 (Ferrari and Thomas, 1994) . In response to mitogenic signals, S6 the rapamycin-resistant p70 s6k mutant, while preventing rapamycin from inhibiting the translation of 5ЈTOP becomes increasingly phosphorylated on five of seven serines residing at the carboxy-terminus of the protein, Steitz, 1989) and, more recently, in the replication of Sindbis virus (Pardigon and Strauss, 1996) , as well as including S235, S236, S240, S244 and S247 (Krieg et al., stimulating the translation of viral and cap-dependent 1988). Moreover, phosphate release studies have shown mRNAs (Svitkin et al., 1994a (Svitkin et al., ,b, 1996 . La possess an that phosphorylation proceeds in an ordered fashion in vivo inherent ATPase activity (Bachmann et al., 1990) and an and in vitro: S236→S235 or S240→S244→S247 (Bandi RNA-binding motif (Chambers et al., 1988), and binds to et al., 1993) . Employing a number of approaches, S6 has poly(U) with high avidity (Topfer et al., 1993) . La derived been localized to the small head region of the 40S from extracts of either resting or serum-stimulated cells ribosomal subunit, where it has been cross-linked to a binds with the same ability to the 5ЈTOP as measured number of translational components residing in or at the by mobility shift assays employing an oligonucleotide tRNA/mRNA-binding site, including the 3Ј end of 18S identical in sequence to the first 34 bases of ribosomal rRNA, tRNA, initiation factors and mRNA (Nygard and protein L32 (Kaspar et al., 1992) . Furthermore, binding Nilsson, 1990) . In addition, S6 is one of the few proteins is cap independent and is competed away effectively by of the 40S ribosomal subunit that has been cross-linked an oligonucleotide corresponding to the polypyrimidine directly to the 28S rRNA component of the 60S subunit tract or poly(U) (Kaspar et al., 1992) . Mutations in the (Nygard and Nilsson, 1990) , suggesting that it may lie at polypyrimidine tract, which ablate the translational control the interface between the two ribosomal subunits. The of 5ЈTOP mRNAs, also impair the binding of La possibility that S6 may interact with mRNA and/or initi- (Pellizzoni et al., 1996) . To date, no direct relationship ation factors is of potential functional significance.
in vivo has been demonstrated between the binding of La Nonetheless, mutation of the serines equivalent to S235 to the polypyrimidine tract and the translational upand S236 in the Saccharomyces cerevisiae homologue of regulation of 5ЈTOP mRNAs. Given La's ability to bind S6, which lacks the last three sites of phosphorylation, to 5ЈTOP mRNA polypyrimidine tracts independently of has little effect on global translation, vegetative growth growth state and, in parallel, to facilitate cap-dependent or the pattern of translation (Johnson and Warner, 1987) .
translation, it is difficult to conceive a functional role for However, S.cerevisiae ribosomal proteins and elongation La as a selective repressor of 5ЈTOP mRNA translation. factors do not contain 5ЈTOPs and, unlike mammals, However, a model could be envisaged whereby a second S.cerevisiae appears to acutely regulate the production of translational factor, such as phosphorylated S6, could bind protein synthetic machinery at the transcriptional level.
to La in a specific context, such as the polypyrimidine Furthermore, it is clear in mammalian cells that the p70 s6k tract, leading to the selective translation of 5ЈTOP mRNAs signalling pathway is not the only signalling pathway ( Figure 6 ). leading to the selective translational up-regulation of Consistent with the role of p70 s6k in regulating 5ЈTOP-5ЈTOP mRNAs, as neither rapamycin nor the dominantcontaining ribosomal protein mRNAs, we have found recently that a P element-induced mutation in the Drosointerfering p70 s6k A229 mutant completely ablate the transphila homologue (M.Stewart, F.Zilberman, C.Berry, lational up-regulation of 5ЈTOP mRNAs (Figures 1 and  S .Kozma, and G.Thomas, unpublished data) of the p70 s6k 3, Jefferies et al., 1994a) . It may be that in S.cerevisiae gene (Stewart et al., 1996) exhibits a phenotype markedly the functional importance of S6 phosphorylation is masked resembling that of the Minute, bobbed and mini mutants, by a redundant signalling pathway. Certainly, many funcwhich affect the ribosomal protein and rRNA genes of tional pathways in S.cerevisiae are redundant and require Drosophila (see Andersson et al., 1996) . Interestingly, advanced genetic approaches to uncover their importance, rapamycin also has been shown to inhibit rRNA synthesis such as the employment of synthetic lethal screens (see (Mahajan, 1994) as well as cyclin D 1 -Cdk4 and cyclin Posas et al., 1996) . In support of increased S6 phosphoryla-E-Cdk2 activation (Kato et al., 1994; Nourse et al., 1994) , tion playing a critical role in translational up-regulation which through hyper-phosphorylation of the retinoblasof 5ЈTOP mRNAs, earlier studies demonstrated that 40S toma protein have been implicated in the regulation of ribosomal subunits, containing predominantly the highly both RNA polymerase I and III (Cavanaugh et al., 1995 ; phosphorylated forms of S6, bound poly(U) more strongly White et al., 1996) , responsible for regulating rRNA than unphosphorylated ribosomes and that poly(U) dissocisynthesis. The inhibitory effects of rapamycin on cyclin ated from the phosphorylated ribosomes much more slowly D 1 -Cdk4 and cyclin E-Cdk2 are thought to be mediated than from their unphosphorylated counterparts (Gressner by the p27 inhibitor (Kato et al., 1994; Nourse et al., and van de Leur, 1980) . As the 5ЈTOP is mostly made up 1994); however, cells derived from p27 knockout animals of Us, it might be speculated that phosphorylated forms have been shown to be either completely (Nakayama of S6 interact directly with polypyrimidine tract-containing et al., 1996) or partially rapamycin sensitive for growth mRNAs, increasing the possibility of forming a stable (Luo et al., 1996) , consistent with data which would initiation complex (see Figure 6) .
suggest an alternative target (Kato et al., 1994) . At this In elucidating the signalling pathway leading to the point, it will be important to establish whether the effects translational up-regulation of 5ЈTOP mRNAs, it should of rapamycin on cyclin D 1 -Cdk4 and cyclin E-Cdk2 be noted that, in Xenopus and mouse cells, a protein of activation and rRNA synthesis are mediated in part through M r 57 kDa has been cross-linked specifically to the p70 s6k . Employing the p70 s6k constructs described here polypyrimidine tract of ribosomal protein mRNAs L4 and should make it possible to resolve these issues. L32 (Kaspar et al., 1992; Cardinali et al., 1993) . Recent studies have identified this protein as the La autoantigen Materials and methods (Pellizzoni et al., 1996) , which elicits autoantibody producCell culture, cytoplasmic polysome extraction and sucrose tion in patients with systemic lupus erythematosus and gradients Sjögren's syndrome. La was first implicated in RNA NIH 3T3 cell lines were seeded and maintained on 15 cm tissue culture plates in standard Dulbecco's modified Eagles medium (DMEM) polymerase III transcription termination (Gottlieb and containing 10% fetal calf serum (FCS) and 100 μg/ml of G418 (geneticin) constructs used were tagged by the insertion of the myc 9E10 epitope immediately following the p70 s6k isoform initiator ATG codon as for maintaining the stable transfectants. NIH 3T3 cells were grown tõ 80% confluence, the medium was replaced by DMEM containing 0.5% previously described (Ming et al., 1994) . Site-directed mutagenesis was performed using the Altered site II Mutagenesis System (Promega) FCS and the cells cultured for 40 h. The medium was then replaced by DMEM containing 0.1% bovine serum albumin (BSA) and the cells according to the manufacturer's instructions. All p70 s6k constructs were placed in a cytomegalovirus-driven expression plasmid (CMV-plasmid) cultured for a further 1 h before treating the cells as described in the figure legends. Rapamycin (2 mM in ethanol) was diluted 1:100 in and confirmed by DNA sequencing. Creation of the myc-p70 s6k A229 and the myc-p70 s6k E389 construct are described in . medium before being added to the cells at a final concentration of 20 nM. Cytoplasmic extracts were prepared as described for Swiss 3T3 HA-p44 mapk construct was a gift from J.Pouysségur (Meloche et al., 1992) . The construction of the p70 s6k -GST is to be described elsewhere. cells . Human kidney 293 cells were maintained on 10 cm tissue culture plates in DMEM containing 10% FCS. Human 293 cells were seeded at 1ϫ10 6 cells per 10 cm plate and cultured for Acknowledgements 24 h. They were then transfected by a modified calcium phosphate method . After 12-14 h, the cells were washed
We are indebted to Dr N.Pullen for providing the p70 s6k -GST constructs three times then cultured in DMEM without serum for 24-26 h. For and Dr S.C.Kozma for discussions concerning the dominant-interfering extracts, the cells were washed twice with ice-cold phosphate-buffered mutation. We thank Drs S.C.Kozma, W.Krek and P.Matthias for their saline (PBS) and lysed directly on the plate by the addition of 300 μl critical reading of the manuscript. We would also like to thank O.Meyuhas of hypotonic lysis buffer containing 1.5 mM KCl, 2.5 mM MgCl 2 , 5 for providing NIH 3T3 cells stably expressing the mutant mRNAs as mM Tris-HCl pH 7.4, 1% Triton X-100 and 1% deoxycholate. The well as the chimeric constructs. This work has been supported by lysate was collected and treated as for Swiss 3T3 cells (Jefferies et al., fellowships from EMBO (S.F.) and the HFSPO (P.B.D. and R.B.P.) and 1994b). Briefly, 300 μl of cytoplasmic extract were applied to linear a grant from the HFSPO (H.B.J.J. and G.T.). sucrose gradients containing 80 mM NaCl, 5 mM MgCl 2 , 20 mM TrisHCl pH 7.4, and 1 mM dithithreitol, which were centrifuged in an SW41 Beckmann rotor at 36 000 r.p.m. for 2 h at 4°C. Fractionation of the
